scholarly journals Smac/DIABLO can predict postoperative delirium in elderly patients after cardiac surgery : A prospective nested case-control study

Author(s):  
Xin Ding ◽  
Zeping Li ◽  
Lei Lei ◽  
Muhuo Ji ◽  
Jianjun Yang

Background:Postoperative delirium (POD) is a common complication following cardiac surgery. Mitochondrial injury, demonstrated by excessively activated oxidative stress and regulating cell apoptosis, has been reported to contribute to POD. [Mitophagy](https://www.geenmedical.com/article?id=34752757&type=true), apoptosis, pyroptosis, ferroptosis had been known to play a critical role in degenerative nervous system diseases. However, the serum change of Smac/DIABLO in POD induced by cardiac surgery/anesthesia is still undetermined. We designed the study to determine the expression level of SMAC/DIABLO in POD patients. Methods:A nested case-control study was performed, including 21 POD patients and a matched group of 63 non-POD controls.

2017 ◽  
Vol 6 (3) ◽  
pp. 5
Author(s):  
JuanCarlos Núñez-Enríquez ◽  
IsabelZnaya Ramírez-Flores ◽  
Maribel Ibarra-Sarlat ◽  
Vivian Neme-Bechara ◽  
Alejandro Herrera-Landero ◽  
...  

2020 ◽  
Vol 38 (6_suppl) ◽  
pp. 435-435
Author(s):  
Daniel Keizman ◽  
Ido Wolf ◽  
Hadas Dresler ◽  
David Sarid ◽  
Avivit Peer ◽  
...  

435 Background: Oxidative stress may be involved in tumorigenesis processes. Uric acid is an important natural antioxidant that may reduce oxidative stress. Allopurinol is a commonly used uric acid lowering agent. There are conflicting data regarding the association between allopurinol use and cancer incidence. In the present nested case control study, we aimed to evaluated the association between allopurinol use and urologic malignancies in a large western population. Methods: conducted a nested case-control study within a population-representative database from the United Kingdom (THIN). Study cases were defined as individuals with any diagnostic code of prostate cancer, bladder cancer, or renal cell carcinoma. For every case, four eligible controls were matched on age, gender, practice site, time of diagnosis, and duration of follow-up. Exposure of interest was any allopurinol use prior to cancer diagnosis. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for urologic malignancies were estimated using conditional logistic regression. Adjustment was performed for factors including smoking, BMI, and diabetes. Results: The study population included: for bladder cancer 13440 and 52421 matched controls, prostate cancer 27212 cases and 105940 controls, RCC 1547 cases and 6066 controls. Allopurinol use was associated with a significantly increase of risk for bladder cancer (adjusted OR 1.2, 95%CI 1.09-1.32, p<0.001). prostate cancer (adjusted OR 1.1, 95%CI 1.03-1.,17, p=0.003), RCC (adjusted OR 1.32, 95%CI 1-1..75, p=0.05). In a sensitivity analyses we observed similar associations when alopurinol use was initiated more than two years prior to cancer diagnosis, for bladder cancer (adjusted OR 1.2, 95%CI 1.08-1.33, p=0.001), prostate cancer (adjusted OR 1.09, 95%CI 1.02-1.16, p=0.01), RCC (adjusted OR 1.09, 95%CI 0.78-1.53, p=0.62). Conclusions: Allopurinol use may be associated with an increased risk for urologic malignancies.


2011 ◽  
Vol 140 (5) ◽  
pp. S-347-S-348
Author(s):  
Anke M. Leufkens ◽  
Fränzel J. van Duijnhoven ◽  
Sjoukje Woudt ◽  
Peter D. Siersema ◽  
Hendrik B. Bueno-de-Mesquita

Blood ◽  
2011 ◽  
Vol 117 (16) ◽  
pp. 4218-4225 ◽  
Author(s):  
Alexander P. J. Vlaar ◽  
Jorrit J. Hofstra ◽  
Rogier M. Determann ◽  
Denise P. Veelo ◽  
Frederique Paulus ◽  
...  

Abstract Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related morbidity and mortality. Both antibodies and bioactive lipids that have accumulated during storage of blood have been implicated in TRALI pathogenesis. In a single-center, nested, case-control study, patients were prospectively observed for onset of TRALI according to the consensus definition. Of 668 patients, 16 patients (2.4%) developed TRALI. Patient-related risk factors for onset of TRALI were age and time on the cardiopulmonary bypass. Transfusion-related risk factors were total amount of blood products (odds ratio [OR] = 1.2; 95% confidence interval [CI], 1.03-1.44), number of red blood cells stored more than 14 days (OR = 1.6; 95% CI, 1.04-2.37), total amount of plasma (OR = 1.2; 95% CI, 1.03-1.44), presence of antibodies in donor plasma (OR = 8.8; 95% CI, 1.8-44), and total amount of transfused bioactive lipids (OR = 1.0; 95% CI, 1.00-1.07). When adjusted for patient risk factors, only the presence of antibodies in the associated blood products remained a risk factor for TRALI (OR = 14.2; 95% CI, 1.5-132). In-hospital mortality of TRALI was 13% compared with 0% and 3% in transfused and nontransfused patients, respectively (P < .05). In conclusion, the incidence of TRALI is high in cardiac surgery patients and associated with adverse outcome. Our results suggest that cardiac surgery patients may benefit from exclusion of blood products containing HLA/HNA antibodies.


2007 ◽  
Vol 84 (4) ◽  
pp. 1166-1173 ◽  
Author(s):  
Basel Ramlawi ◽  
Hasan Otu ◽  
Shigetoshi Mieno ◽  
Munir Boodhwani ◽  
Neel R. Sodha ◽  
...  

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i412-i412
Author(s):  
Loutradis Charalampos ◽  
Maria Moschopoulou ◽  
Foteini Ampatzidou ◽  
Afroditi Mpoutou ◽  
Charilaos-Panagiotis Koutsogiannidis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document